The time it takes to correctly diagnose endometriosis could be slashed from seven years to just a few weeks with a new, non-invasive test from Nedlands-based Proteomics International.
Perth-based Proteomics International has partnered with the University of Melbourne and the Royal Women's Hospital to develop a non-invasive blood test for endometriosis.
It has taken over 15 years, but Perth-based medical technology company Proteomics International is now launching a commercial product targeted at the US.
Shares in Proteomics International Laboratories have jumped more than 8 per cent in early trading, after the Nedlands-based firm announced a collaboration agreement with a US pharmaceutical company.
Shares in Nedlands-based Proteomics International Laboratories skyrocketed on news it had produced and validated a predictive test for the diagnosis of diabetic kidney disease.
Nedlands-based Proteomics International Laboratories has made a solid debut on the ASX today, closing 2.5 cents above its issue price at 22.5 cents per share, with about 1.13 million shares changing hands.
Nedlands company Proteomics International Laboratories is hoping for increased support for its initial public offering after finalising an agreement with a Chinese drug development business.
